McKesson Corporation Board Of Directors Elects N. Anthony Coles As New Independent Director

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

As a next step in a series of corporate governance modifications, McKesson Corporation (NYSE: MCK) today announced that its Board of Directors has elected N. Anthony Coles, M.D., as a new independent director, effective April 29, 2014. In connection with Dr. Coles’ election, the size of the Board of Directors was increased from nine to ten members, nine of whom are independent.

Help employers find you! Check out all the jobs and post your resume.

Back to news